Found: 21
Select item for more details and to access through your institution.
Chronological analysis of the gut microbiome for efficacy of atezolizumab‐based immunotherapy in non‐small cell lung cancer: Protocol for a multicenter prospective observational study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2829, doi. 10.1111/1759-7714.14640
- By:
- Publication type:
- Article
Remotely shared CT‐derived presurgical understanding of lung cancer: A randomized trial.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2823, doi. 10.1111/1759-7714.14637
- By:
- Publication type:
- Article
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2792, doi. 10.1111/1759-7714.14627
- By:
- Publication type:
- Article
Gut microbiota shed new light on the management of immune‐related adverse events.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2681, doi. 10.1111/1759-7714.14626
- By:
- Publication type:
- Article
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2776, doi. 10.1111/1759-7714.14621
- By:
- Publication type:
- Article
What does radiomics do in PD‐L1 blockade therapy of NSCLC patients?
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2669, doi. 10.1111/1759-7714.14620
- By:
- Publication type:
- Article
Log odds of positive lymph nodes is a robust predictor of survival and benefits from postoperative radiotherapy in stage IIIA‐N2 resected non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2767, doi. 10.1111/1759-7714.14617
- By:
- Publication type:
- Article
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2817, doi. 10.1111/1759-7714.14615
- By:
- Publication type:
- Article
Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2812, doi. 10.1111/1759-7714.14613
- By:
- Publication type:
- Article
Dietary acid load and esophageal cancer risk: A case‐control study.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2759, doi. 10.1111/1759-7714.14612
- By:
- Publication type:
- Article
Short‐term outcomes in patients with lung cancer‐associated acute ischemic stroke.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2751, doi. 10.1111/1759-7714.14611
- By:
- Publication type:
- Article
Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2786, doi. 10.1111/1759-7714.14610
- By:
- Publication type:
- Article
Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2808, doi. 10.1111/1759-7714.14609
- By:
- Publication type:
- Article
Retrospective analysis of independent predictors of progression‐free survival in patients with EGFR mutation‐positive advanced non‐small cell lung cancer receiving first‐line osimertinib.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2741, doi. 10.1111/1759-7714.14608
- By:
- Publication type:
- Article
Division of the intersegmental demarcation using the "modified hand‐tearing method" is safe and feasible in thoracoscopic anatomical segmentectomy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2732, doi. 10.1111/1759-7714.14607
- By:
- Publication type:
- Article
Lung‐specific exosomes for co‐delivery of CD47 blockade and cisplatin for the treatment of non–small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2723, doi. 10.1111/1759-7714.14606
- By:
- Publication type:
- Article
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2711, doi. 10.1111/1759-7714.14604
- By:
- Publication type:
- Article
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2799, doi. 10.1111/1759-7714.14602
- By:
- Publication type:
- Article
Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2699, doi. 10.1111/1759-7714.14596
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of the new oncological drug durvalumab in Italian patients with stage III non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2692, doi. 10.1111/1759-7714.14531
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 19, p. 2667, doi. 10.1111/1759-7714.14033
- Publication type:
- Article